UPDATED Mar 16, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
HEIJM | €16.10 | -2.1% | 31.3% | €431.9m | €17.75 | PE7.2x | E10.2% | 5.5% | Capital Goods | ||
BACE | US$10.00 | 0% | 0% | US$115.7m | n/a | PE7.8x | n/a | n/a | Diversified Financials | ||
BBED | €5.98 | 0.3% | 111.3% | €164.7m | €6.10 | PE21.5x | E15.3% | 2.5% | Retail | ||
ECT | €7.30 | -7.0% | -2.7% | €7.3m | n/a | PS15.4x | n/a | 0% | Real Estate Management and Development | ||
BEVER | €2.52 | 0% | n/a | €43.0m | n/a | PS40.2x | n/a | n/a | Real Estate Management and Development | ||
BESI | €141.45 | -5.3% | 87.1% | €10.9b | €154.25 | PE61.5x | E25.0% | 1.5% | Semiconductors | ||
GLPG | €31.26 | -1.2% | -14.8% | €2.1b | €39.43 | PS8.6x | E-29.0% | n/a | Pharmaceuticals & Biotech | ||
TOM2 | €7.02 | -1.3% | -7.4% | €896.1m | €9.63 | PS1.5x | E99.1% | n/a | Software | ||
HAL | €122.80 | -0.5% | 1.2% | €11.1b | €137.33 | PE8.2x | E-1.4% | 2.3% | Diversified Financials | ||
SIFG | €10.52 | 5.9% | -8.7% | €314.4m | €13.33 | PE28.9x | E44.2% | 0% | Capital Goods | ||
ADYEN | €1,457.00 | -1.7% | 5.2% | €45.2b | €1,561.77 | PE64.7x | E18.9% | n/a | Diversified Financials | ||
MT | €24.22 | 1.4% | -3.1% | €19.8b | €31.56 | PE23.5x | E38.4% | 1.9% | Materials | ||
RAND | €50.40 | -0.9% | -9.6% | €8.9b | €51.12 | PE14.5x | E9.2% | 4.5% | Commercial Services | ||
BAI | €0.72 | 4.3% | -71.2% | €84.6m | €2.50 | PS6.6x | E56.6% | n/a | Pharmaceuticals & Biotech | ||
HOLCO | €91.00 | 1.1% | -24.2% | €78.3m | n/a | PE19.4x | n/a | 3.7% | Materials | ||
VVY | €0.56 | 9.4% | -96.0% | €14.6m | €41.57 | PB0.4x | E68.2% | n/a | Pharmaceuticals & Biotech | ||
PHARM | €1.05 | -0.8% | 13.9% | €704.6m | €1.90 | PS3.1x | E49.1% | n/a | Pharmaceuticals & Biotech | ||
IRIS | US$10.00 | 0% | n/a | US$57.5m | n/a | PE114x | n/a | n/a | Diversified Financials | ||
NEDAP | €67.40 | -0.9% | 17.8% | €441.7m | €63.00 | PE20.5x | E15.2% | 4.7% | Tech | ||
ASM | €553.10 | -4.2% | 71.2% | €27.2b | €572.10 | PE36.2x | E11.1% | 0.5% | Semiconductors | ||
FUR | €21.18 | -2.8% | 95.2% | €2.4b | €24.68 | PE9.4x | E6.5% | 1.9% | Capital Goods | ||
PBH | €2.72 | -0.4% | -3.2% | €15.4m | n/a | PE55.9x | n/a | 0% | Retail | ||
FAST | €24.45 | -0.4% | -26.4% | €462.3m | €40.67 | PS9.3x | E68.6% | n/a | Retail | ||
AALB | €43.53 | 2.4% | 3.9% | €4.8b | €48.36 | PE15.2x | E7.0% | 2.6% | Capital Goods |